Patients with glaucoma will be randomized to Automatic Self Transcending Meditation (ASTM) plus Treatment as Usual (TAU) or TAU alone to assess changes in Health-related quality of life (HRQoL). HRQoL is a vital construct focusing on impact of health on quality of life. HRQoL data is used in economic evaluations, a component of health economics that compares the cost and consequences of alternative courses of action. This helps policy-makers make complex financial decisions. Along with HRQoL we will measure changes in extent of depression as well as anxiety. Previously published data lacks information of HRQoL in patients with glaucoma. Through this study we shall attempt to correlate HRQoL in this population and assess if ASTM confers changes in HRQoL along with depressive and anxiety symptoms.
Inclusion Criteria: * glaucoma suspects or have mild to severe glaucoma * at least 18 years of age or above * deemed competent such as no language issues or communication barriers, no self-reported or physician diagnosed mental health disorder besides having depressive and anxiety symptoms * have sufficient hearing to be able to follow verbal instructions and able to sit without physical discomfort for 30 minutes * willing and able to attend 4 initial ASTM training sessions and at least 75% of weekly and 80% of bi-weekly follow up sessions * willing to dedicate 20 minutes twice per day to ASTM practice at their own home. Exclusion Criteria: * Actively suicidal as per self-report (scoring 2 or more on item 9 of the PHQ-9) or on assessment by the physician. * They are currently participating in other similar studies * Currently practicing any type of formal meditation, mindfulness or breathing techniques regularly * unable or unwilling to answer survey questions.